Andy Scharenberg

Co-Founder & CEO at Umoja Biopharma

Andy Scharenberg is the co-founder and CEO of Umoja Biopharma. Andy has over twenty years of experience in the biotech industry, holding various leadership positions at companies such as MPM Capital, Casebia Therapeutics, Generation Bio, bluebird bio, and Cellectis therapeutics. Andy is also a founding member of the Board of Directors at Pregenen and a professor of Pediatrics and Immunology at the University of Washington. Andy's experience and expertise have been instrumental in the success of Umoja Biopharma.

Andy Scharenberg is an MD who specializes in medicine. Andy attended the University of North Carolina School of Medicine.

Timeline

  • Co-Founder & CEO

    Current role